CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

The best AI stocks to buy now

Artificial intelligence stocks maintain their allure, thanks to industry momentum and appealing valuations.
stocks

ASX share undervalued despite solid growth

First-quarter performance exceeds expectations.
stocks

Chart of the Week: 3 undervalued US tech shares

Our US analysts’ top tech opportunities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.7054.500.62%
CAC 407,803.3373.640.95%
DAX 4025,087.27280.301.13%
Dow JONES (US)51,654.95423.310.83%
FTSE 10010,552.05110.451.06%
HKSE24,211.35425.561.79%
NASDAQ27,366.17172.830.64%
Nikkei 22569,030.9211.19-0.02%
NZX 50 Index13,749.3557.500.42%
S&P 5007,811.5446.180.59%
S&P/ASX 2008,716.6055.700.64%
SSE Composite Index3,813.791.890.05%

Market Movers